David M. Epstein
2021
In 2021, David M. Epstein earned a total compensation of $5.1M as President and Chief Executive Officer at Black Diamond Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $228,735 |
---|---|
Option Awards | $4,235,494 |
Salary | $538,201 |
Other | $87,795 |
Total | $5,090,225 |
Epstein received $4.2M in option awards, accounting for 83% of the total pay in 2021.
Epstein also received $228.7K in non-equity incentive plan, $538.2K in salary and $87.8K in other compensation.
Rankings
In 2021, David M. Epstein's compensation ranked 2,566th out of 12,415 executives tracked by ExecPay. In other words, Epstein earned more than 79.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,566 | 79th |
Manufacturing | 1,022 | 81st |
Chemicals And Allied Products | 395 | 83rd |
Drugs | 346 | 84th |
Biological Products, Except Diagnostic Substances | 105 | 77th |
Epstein's colleagues
We found three more compensation records of executives who worked with David M. Epstein at Black Diamond Therapeutics in 2021.